Last Updated: November 13, 2026

Details for New Drug Application (NDA): 218419

« Back to Dashboard

NDA 218419 describes LISINOPRIL, which is a drug marketed by Annora Pharma, Accord Hlthcare, Aurobindo, Chartwell Rx, Heritage, Heritage Pharma, Hikma, Invagen Pharms, Lupin, Prinston Inc, Rising, Sciegen Pharms, Strides Pharma, Sun Pharm Inds Ltd, Teva, Watson Labs, Wockhardt Bio Ag, Aiping Pharm Inc, Epic Pharma Llc, Macleods Pharms, and Pharmobedient, and is included in thirty-three NDAs. It is available from thirty-four suppliers. Additional details are available on the LISINOPRIL profile page.

The generic ingredient in LISINOPRIL is hydrochlorothiazide; lisinopril. There are two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

Summary for 218419

Tradename:	LISINOPRIL
Applicant:	Annora Pharma
Ingredient:	lisinopril
Patents:	0

Medical Subject Heading (MeSH) Categories for 218419

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cardiotonic Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;ORAL			Strength	1MG/ML
Approval Date:	Aug 20, 2026	TE:	AA	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.